Orange Book product · Brand (NDA)
QNASL
BECLOMETHASONE DIPROPIONATE
At a glance
Dec 17, 2014
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 17, 2014
11 yr 8 mo ago
Today
Patent 10188811 expires
Listed drug product patent expiration.
Oct 21, 2031
in 5 yr 5 mo
Pharmaceutical detail
Active ingredient
BECLOMETHASONE DIPROPIONATE
Strength
0.04MG/ACTUATION
Dosage form
AEROSOL, METERED
Route
NASAL
TE code
Not listed
Application
NDA 202813
Product number
002
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2017QVAR REDIHALERBrand (NDA)
NDA 207921 · NORTON WATERFORD
- 2000QVAR 40Brand (NDA)
NDA 020911 · TEVA BRANDED PHARM
- 1996VANCERIL DOUBLE STRENGTHBrand (NDA)
NDA 020486 · SCHERING
- —BECLOVENTBrand (NDA)
NDA 018153 · GLAXOSMITHKLINE
- —VANCERILBrand (NDA)
NDA 017573 · SCHERING
- —BECONASEBrand (NDA)
NDA 018584 · GLAXOSMITHKLINE
- —VANCENASEBrand (NDA)
NDA 018521 · SCHERING
- 2025BECLOMETHASONE DIPROPIONATEGeneric (ANDA)
ANDA 213811 · AMNEAL IRELAND LTD
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10188811 | Oct 21, 2031 | in 5 yr 5 mo | Product |
